Related Experiment Video
Updated: May 20, 2026

13:24
Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
Published on: April 11, 2016
The future of genomics in pathology
F1000 Medicine Reports
|July 18, 2012
Summary
Cheap and fast whole genomic data can revolutionize pathology, enabling early disease diagnosis and personalized treatments. This review explores the technological advances and necessary changes for this pathology revolution.
Area of Science:
- Genomic Medicine
- Pathology Informatics
Background:
- Technological advancements are making whole genomic data more accessible and affordable.
- Genomic data holds significant potential to transform disease diagnosis and treatment.
Purpose of the Study:
- To review recent technological advances in genomic data generation and analysis.
- To outline the necessary changes for integrating genomic data into routine pathology practice.
- To discuss the potential of genomics to revolutionize pathology.
Main Methods:
- Review of current literature on genomic technologies and their applications in pathology.
- Analysis of the potential impact of these technologies on diagnostic and therapeutic strategies.
- Identification of infrastructural and educational requirements for widespread adoption.
Main Results:
- Rapid progress in sequencing technology offers unprecedented insights into disease mechanisms.
- Genomic data enables precise disease classification and prediction of treatment response.
- Integration requires significant investment in bioinformatics infrastructure and pathologist training.
Conclusions:
- The integration of whole genomic data promises a new era in pathology, shifting towards precision medicine.
- Overcoming challenges in data analysis, interpretation, and clinical implementation is crucial.
- Future pathology practice will be data-driven, offering personalized diagnostics and therapeutics.
Related Concept Videos
Genomics
Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Next-generation Sequencing
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features.
Pharmacogenetics and Pharmacogenomics: Overview
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
Modern Molecular Taxonomy
Advancements in molecular biology have revolutionized the identification and characterization of bacteria, with multiple methods leveraging DNA sequencing for enhanced precision. As sequencing technologies improve and costs decline, these approaches are increasingly used in clinical, environmental, and evolutionary studies.Multilocus Sequence Typing (MLST) examines several housekeeping genes, essential chromosomal genes encoding cellular functions, to distinguish strains. Approximately...
Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...

